These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9171756)

  • 1. Mutant plasma p53 protein levels: prognostication in colorectal carcinoma.
    Wong SK; Seow-Choen F; Leong AP; Ho YH; Aw SE
    Br J Surg; 1997 May; 84(5):664-5. PubMed ID: 9171756
    [No Abstract]   [Full Text] [Related]  

  • 2. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
    Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
    Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-MYB, serum P-53M, genetic instability, labeling index and endoscopic findings in patients with adenoma or colorectal cancer.
    Assisi D; Grassi A; La Penta R; Stigliano V; Greco C; Cianciulli AM; Giannarelli D; Casale V
    J Exp Clin Cancer Res; 2004 Sep; 23(3):469-75. PubMed ID: 15595638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of protein p53 in the stool of patients with colorectal cancer].
    Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
    Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients.
    Jezersek B; Rudolf Z; Novakovic S
    Oncol Rep; 2001; 8(1):77-81. PubMed ID: 11115573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.
    Hirano K; Minamoto T
    Cancer Detect Prev; 2000; 24(4):343-55. PubMed ID: 11059565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
    Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma].
    Shu M; Liu S; Yu P
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):129-32. PubMed ID: 10681823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum p53 antibodies as an early detection marker in colorectal cancer.
    Takeda A; Shimadai H; Iseki H; Saeki T; Koyama I
    Hepatogastroenterology; 2007 Sep; 54(78):2 pages preceeding table of content. PubMed ID: 18019675
    [No Abstract]   [Full Text] [Related]  

  • 17. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
    Singson RP; Alsabeh R; Geller SA; Marchevsky A
    Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.